EarningsQ2 2026 Earnings Report

Filana Therapeutics (FLNA) Q2 2026 Earnings Report

0 Followers

MX:FLNA Q2 2026 EPS Results

Actual EPS-$3.26

Consensus EPS-$4.07

Beat/MissBeat by +$0.81

One Year Ago EPS-$16.65

Actual Revenue$0.00

Expected Revenue$0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ2 2026

Date08/05/2026

TimeBefore Open

Conference CallWednesday, August 5, 2026

MX:FLNA Upcoming Earnings

Filana Therapeutics's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	-4.43 / -	-3.981	―
Aug 05, 2026	2026 (Q2)	-4.07 / -3.26	-16.648	80.43% (+13.39)
May 07, 2026	2026 (Q1)	-4.16 / -3.80	-8.686	56.25% (+4.89)
Mar 12, 2026	2025 (Q4)	-5.43 / -4.70	-10.314	54.39% (+5.61)
Nov 12, 2025	2025 (Q3)	-4.89 / -3.98	-10.495	62.07% (+6.51)
Aug 14, 2025	2025 (Q2)	- / -16.65	2.352	-807.69% (-19.00)
May 08, 2025	2025 (Q1)	- / -8.69	-7.781	-11.63% (-0.90)
Mar 03, 2025	2024 (Q4)	-10.55 / -10.31	-9.048	-14.00% (-1.27)
Nov 07, 2024	2024 (Q3)	-13.21 / -10.50	-11.038	4.92% (+0.54)
Aug 08, 2024	2024 (Q2)	-7.36 / 2.35	-11.4	120.63% (+13.75)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed